Ketoconazole reduces low dose cocaine self-administration in rats
Ketoconazole reduces low dose cocaine self-administration in rats
复制标题
DOI:
10.1016/s0376-8716(98)00108-2
复制
发表时间:
1998-12-01
影响因子:
4.2
通讯作者:
Guerin, GF
中科院分区:
文献类型:
--
作者:
Goeders, NE;Peltier, RL;Guerin, GF
Ketoconazole is an oral antimycotic agent approved by the FDA for the treatment of fungal disease which also blocks the synthesis of adrenocorticosteroids and functions as a glucocorticoid receptor antagonist. In these experiments, adult male Wistar rats were allowed alternating 15-min periods of access to food reinforcement and cocaine self-administration (0.125, 0.25 or 0.5 mg/kg per infusion) during daily 2-h sessions. A I-min timeout separated access to the two reinforcers. Pretreatment with ketoconazole (25 mg/kg, i.p.) significantly decreased plasma corticosterone and reduced low dose (i.e. 0.125-0.25 mg/kg per infusion) cocaine self-administration without affecting food-reinforced responding. In fact, pretreatment with ketoconazole resulted in rates and patterns of self-administration at these doses that were indistinguishable from those observed during cocaine extinction. However, cocaine self-administration at the highest dose tested in these experiments (i.e. 0.5 mg/kg per infusion) was not significantly affected by ketoconazole. These data suggest the potential utility of ketoconazole or related drugs as adjuncts in the treatment of cocaine abuse and further underscore the role for corticosterone in cocaine reinforcement. (C) 1998 Elsevier Science Ireland Ltd. All rights reserved.